Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip McCarthy

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Cerebrovascular Diseases Extra|November 9, 2020
Impact of a Stay-at-Home Order on Stroke Admission, Subtype, and Metrics during the COVID-19 PandemicFnu Rameez, Philip McCarthy, Yao Cheng, et al.
Leukemia & Lymphoma|September 17, 2004
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphomaAsher Chanan-Khan, Tariq Islam, Arif Alam, et al.
Haematologica|October 20, 2022
Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significantGeorge Chen, Megan Herr, Jan Nowak, et al.
American Journal of Hematology|September 17, 2011
Managing cardiac amyloidosis: auto or allotransplant?Ambuga Badari, Karen Brown, Pamela Paplham, et al.
Blood Advances|July 26, 2024
Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapsePeter Voorhees, Vera Suman, Yvonne Efebera, et al.
Plastic and Reconstructive Surgery. Global Open|August 3, 2023
Outcomes of Negative Pressure Wound Therapy on Immediate Breast Reconstruction after MastectomyHaris M Akhter, Collin Macdonald, Philip McCarthy, et al.
Neurology. Clinical Practice|June 3, 2024
Multidisciplinary Approach to Patent Foramen Ovale Closure for Cryptogenic Stroke: Brain-Heart Board ExperienceMuhib Khan, Malgorzata Miller, Philip Mccarthy, et al.
Blood Advances|July 19, 2023
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can helpKevin J Curran, Sarah Nikiforow, Carlos Bachier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002)Asad Bashey, Kouros Owzar, Jeffrey L Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Cerebrovascular Diseases Extra|November 9, 2020
Impact of a Stay-at-Home Order on Stroke Admission, Subtype, and Metrics during the COVID-19 PandemicFnu Rameez, Philip McCarthy, Yao Cheng, et al.
Leukemia & Lymphoma|September 17, 2004
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphomaAsher Chanan-Khan, Tariq Islam, Arif Alam, et al.
Haematologica|October 20, 2022
Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significantGeorge Chen, Megan Herr, Jan Nowak, et al.
American Journal of Hematology|September 17, 2011
Managing cardiac amyloidosis: auto or allotransplant?Ambuga Badari, Karen Brown, Pamela Paplham, et al.
Blood Advances|July 26, 2024
Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapsePeter Voorhees, Vera Suman, Yvonne Efebera, et al.
Plastic and Reconstructive Surgery. Global Open|August 3, 2023
Outcomes of Negative Pressure Wound Therapy on Immediate Breast Reconstruction after MastectomyHaris M Akhter, Collin Macdonald, Philip McCarthy, et al.
Neurology. Clinical Practice|June 3, 2024
Multidisciplinary Approach to Patent Foramen Ovale Closure for Cryptogenic Stroke: Brain-Heart Board ExperienceMuhib Khan, Malgorzata Miller, Philip Mccarthy, et al.
Blood Advances|July 19, 2023
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can helpKevin J Curran, Sarah Nikiforow, Carlos Bachier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002)Asad Bashey, Kouros Owzar, Jeffrey L Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Pageof 6